Many European countries resume AstraZeneca vaccination

Recently, because some people vaccinated with AstraZeneca’s new crown vaccine have symptoms such as blood clots, many European countries have suspended the use of the vaccine and await investigation. The European Medicines Agency (EMA) announced the conclusions of the study at a special meeting held on the 18th that the AstraZeneca vaccine is not linked to the increased risk of blood clots in the vaccinators, and the “benefits of vaccination still outweigh the potential risks.” After the conclusion was announced, many European countries such as France and Germany announced that they would resume AstraZeneca vaccination on the 19th or next week. CNN and many other media reported that after a week of “stopping the storm”, many Europeans have become skeptical about the AstraZeneca vaccine. How can people rebuild their trust in the vaccine? Sensation is the problem facing European leaders.

According to a Reuters report on the 19th, EMA gave an official evaluation result of the AstraZeneca vaccine that has caused a huge controversy in its statement. The agency stated that its safety committee, after deliberation, believes that AstraZeneca vaccine “does not increase the overall risk of blood clots in vaccinators,” and there is no evidence that there are safety issues with AstraZeneca vaccine produced in a particular batch or factory. In general, vaccination with AstraZeneca is still “more advantages than disadvantages” and will help fight the new crown pneumonia epidemic. The World Health Organization also called on countries to continue to use the AstraZeneca vaccine on Thursday, and will announce the results of the organization’s review of the safety of the vaccine on Friday.

EMA’s research team stated that 25 thrombosis cases have been reported among approximately 20 million AstraZeneca vaccinators in the United Kingdom and the European Economic Area, indicating that thrombosis after AstraZeneca vaccination is a “rare” phenomenon. “There may be a difference between the two. The association requires further analysis.” The Wall Street Journal reported on the 19th that the head of the EMA Safety Committee Strauss said that most of the reported thrombotic symptoms after vaccination with AstraZeneca are women, especially young women.

According to a report by Euronews on the 19th, after the EMA “endorsed” the safety of AstraZeneca’s vaccines, Italy took the lead in announcing the restart of AstraZeneca’s vaccination work. Italian Prime Minister Draghi said in a statement on the 18th that AstraZeneca will resume vaccination on the 19th. “The government’s priority is still to get as many vaccinations as possible as soon as possible.” French Prime Minister Castel said that France will resume AstraZeneca vaccination work on the afternoon of the 19th. He himself received the AstraZeneca vaccine on the same day (pictured) to show his confidence in this vaccine. The British Broadcasting Corporation (BBC) reported that British Prime Minister Johnson stated at the government’s epidemic briefing that he would take the lead in vaccinating AstraZeneca on the 19th.

In addition, countries such as Germany, Spain, Portugal, the Netherlands, Cyprus, Latvia and Lithuania will also start using this vaccine again. Norway, Sweden and Denmark said they would evaluate the conclusions of EMA before making a decision.

According to the Wall Street Journal, it is unclear whether the EMA statement will restore confidence in AstraZeneca’s vaccines and put European vaccination activities back on track. According to CNN, a poll in France this week showed that only 22% of the people in the country trust AstraZeneca vaccine. A senior French health official said in an interview on the 18th that the people are now “extremely cautious.” The previous suspension of vaccination caused “panic” to the public and is expected to make more people “hesitate” about getting AstraZeneca vaccine. The New York Times stated that the public’s trust in AstraZeneca’s vaccine “may not be so easy to restore”, but the world urgently needs to rebuild trust in the vaccine, because this vaccine is easier than the Pfizer and Modena vaccines in the United States. Storage and cheaper prices play an important role in the global fight against the new crown pneumonia epidemic, especially in low- and middle-income countries.

German “Der Spiegel” Weekly stated on the 19th that the epidemic in Europe is getting worse, and the speed of vaccination is far behind the spread of the virus. Starting from this Monday, about half of Italy has re-entered the lockdown. France has imposed a four-week lockdown on five areas including Paris from midnight on Friday. Germany announced that the third wave of the epidemic has begun, and Spain will restrict the resurrection. Festival trip. European Commission President Von der Lein said recently that some member states are welcoming the third wave of the epidemic, “we need to speed up vaccination.” The European Union plans to vaccinate 70% of adults by the end of summer.